“Is there really an endocannabinoid system?” Yes. Although not currently included in textbooks and science curriculums, the endocannabinoid system (ECS) does exist. Cannabis is a plant that happens to interact with the ECS to cause a range of effects. Since cannabis’ re-emergence into mainstream health and media, it has been […]
Recent studies show it’s not just humans living longer than ever — our dogs are, too. The average life expectancy of dogs jumped from 10.5 years to 11.8 years between 2002 and 2016, partly because dogs are receiving better care from their humans. But as dogs live longer, they become […]
Cannabis plants have a variety of uses in today’s age and they have been in use for hundreds of years throughout history. Not only is marijuana fun to smoke, but the hemp plant can provide materials for making clothes, rope, paper, and be used for medicinal purposes. The recent buzz […]
By The Canningma‘s Matan Weil, provided exclusively to Benzinga Cannabis. Discovered by scientists in the early 1990s, the endocannabinoid system is responsible for regulating many basic functions throughout the body. The system can be activated by cannabinoids that are naturally created by the body — and those found in the […]
TEL AVIV, Israel, July 1, 2020 /PRNewswire/ — Therapix Biosciences Ltd. (Nasdaq: TRPX) (the “Company” or “Therapix”), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today receipt of Notice of Delisting and Injunction from Israeli Court. Notice of Delisting On June 30, 2020, Therapix Biosciences […]
GW Pharmaceuticals (NASDAQ:GWPH) and Cara Therapeutics (NASDAQ:CARA) often get lumped together as cannabinoid-focused biotechs. However, that label is really only applicable to GW Pharmaceuticals. Although Cara Therapeutics has done some preclinical testing on a cannabinoid receptor agonist and holds some patents on cannabinoid compounds, the company doesn’t really focus on cannabinoid […]
Regulators in the United Kingdom have rescheduled the cannabidiol drug Epidyolex as a Schedule 5 drug, moving the medicine approved to treat severe forms of epilepsy from the much more restrictive Schedule 2 classification. GW Pharmaceuticals, the manufacturer of the medication, announced on Tuesday that the move by the Home […]
Drugs policy Mother of Alfie Dingley says parents are despondent at lack of access to full-extract oil Alfie Dingley, pictured with his mother, Hannah Deacon, is one of only two children to be prescribed full-extract medicinal cannabis oil by the NHS. Photograph: Maggie Deacon/PA There have been no new NHS […]
FDA: Medical cannabis policy As things stand, the FDA has legalised exactly one cannabis-derived drug product, Epidiolex (cannabidiol). The institution has also approved three synthetic drugs, Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). The cannabinoid (CBD) product, Epidiolex, is only used in cases of two rare, severe forms of epilepsy. […]
In one study, patients with epilepsy who used medical cannabis were nearly half as likely to have needed an emergency department visit within the last 30 days as was a control group. In the other study, 3 of 54 subjects who used medical cannabis showed signs of possible cannabis use […]
